Savior Lifetec Corporation (TPEX:4167)
19.00
-0.20 (-1.04%)
Feb 11, 2026, 1:30 PM CST
Savior Lifetec Revenue
Savior Lifetec had revenue of 282.48M TWD in the quarter ending September 30, 2025, a decrease of -15.03%. This brings the company's revenue in the last twelve months to 1.16B, down -7.92% year-over-year. In the year 2024, Savior Lifetec had annual revenue of 1.22B with 15.91% growth.
Revenue (ttm)
1.16B
Revenue Growth
-7.92%
P/S Ratio
5.14
Revenue / Employee
3.02M
Employees
384
Market Cap
5.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.22B | 167.05M | 15.91% |
| Dec 31, 2023 | 1.05B | -215.47M | -17.02% |
| Dec 31, 2022 | 1.27B | -478.04M | -27.41% |
| Dec 31, 2021 | 1.74B | -83.46M | -4.57% |
| Dec 31, 2020 | 1.83B | 508.55M | 38.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sinphar Pharmaceutical | 3.35B |
| Panion & Bf Biotech | 2.04B |
| Mycenax Biotech | 649.64M |
| Pharmosa Biopharm | 136.72M |
| OBI Pharma | 49.29M |
| UnicoCell Biomed | 34.58M |
| AnnJi Pharmaceutical | 23.85M |
| Locus Cell | 5.18M |